Feng Li

Title: The Innovations of Inventor Feng Li

Introduction

Feng Li is an accomplished inventor based in Sugar Land, Texas. With two patents to his name, he has made significant contributions to the field of biochemistry, particularly in compounds that target various receptors for therapeutic purposes.

Latest Patents

Feng Li's latest patents focus on advancements in vascular therapies and imaging technologies. The first patent, "Multivalent ligands targeting VEGFR," reveals compounds designed to target vascular endothelial growth factor receptors. These compounds are essential for therapy and imaging related to conditions that involve VEGFR expression. Additionally, this patent describes methods for synthesizing these compounds and utilizing them for detection or imaging of VEGFR-expressing cells.

His second patent, "Labeled, non-peptidic, multivalent integrin antagonist compounds," details multivalent integrin-receptor antagonists that serve various therapeutic, prophylactic, and diagnostic purposes. These compounds have shown promise in the imaging, detection, and quantitation of biological samples, particularly in the context of proliferative diseases like cancer. The invention also touches on formulations that enhance the efficacy of these compounds in medical applications.

Career Highlights

Feng Li has worked with prestigious institutions, including The Methodist Hospital Research Institute and The Methodist Hospital System. His role in these organizations has allowed him to be at the forefront of innovative research and development in therapeutic technologies.

Collaborations

Throughout his career, Feng has collaborated with other skilled professionals including Zheng Li and King Chuen Li. These partnerships have fostered an environment of knowledge sharing, enhancing the potential for groundbreaking discoveries in their respective fields.

Conclusion

With a strong background in medicinal chemistry and a commitment to innovative research, Feng Li continues to make strides in the development of compounds that can significantly impact therapeutic interventions. His patents underscore the importance of research in improving health outcomes for various diseases, paving the way for future advancements in medical science.